GO:0006869 lipid transport: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0006869 lipid transport describes the directed movement of lipids into, out of, or within a cell, or between cells, by means of an agent such as a transporter or pore.
Lipid transport is essential for membrane biogenesis, energy homeostasis, and cell signaling, and defects are linked to metabolic, infectious, and neurodegenerative diseases [2,3,8].
ATP-binding cassette (ABC) transporters and START-domain proteins are central protein families that mediate lipid transport across membranes and between organelles [3,4,8].
Structural and mechanistic studies of bacterial and human lipid transporters reveal conserved architectures and substrate-handling strategies [4,6,7].
CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of lipid transport genes in health and disease [2,8].
EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate lipid transport research [2,3].

Description

Lipid transport (GO:0006869) is a fundamental biological process that ensures the directed movement of lipids into, out of, or within a cell, or between cells, using transporters, pores, or carrier proteins. Lipids are hydrophobic or amphipathic molecules that require specialized machinery to traverse aqueous environments, and their correct distribution is critical for membrane integrity, energy storage, and signal transduction [2,3]. Dysregulation of lipid transport is increasingly recognized as a driver of human disease, including atherosclerosis, obesity, cancer, and infections [2,5,8]. Researchers studying lipid transport need robust experimental systems to dissect the molecular players and pathways involved. This article integrates authoritative GO annotation with real PubMed literature to provide a research-grade overview of lipid transport, its key genes, regulatory mechanisms, and the CRISPR-based methods used to study it [1,3,4,8].

lipid transport At A Glance

GO ID GO:0006869
GO term lipid transport
Ontology biological_process
Synonym none
Major function Directed movement of lipids into, out of, or within a cell, or between cells, via transporters or pores
Definition source QuickGO
Related molecular functions lipid transporter activity, lipid binding, ATPase-coupled lipid transmembrane transporter activity
Related cellular components membrane, transporter complex, extracellular region
Related biological processes lipid metabolic process, membrane organization, lipid homeostasis

What Is GO:0006869?

According to the Gene Ontology, GO:0006869 lipid transport is defined as the directed movement of lipids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. This process encompasses the translocation of fatty acids, phospholipids, sterols, sphingolipids, and other lipid species across membranes and between cellular compartments, often mediated by dedicated transport proteins [1,3,4].

Why Is lipid transport Important in Cell Biology?

Lipid transport is essential for maintaining cellular lipid homeostasis, membrane dynamics, and energy balance, and its dysfunction contributes to a broad spectrum of human diseases, including metabolic disorders, cardiovascular disease, cancer, and infectious diseases [2,3,5,8]. Understanding the molecular mechanisms of lipid transport provides opportunities for therapeutic intervention and biomarker discovery [4,7].
Maintains membrane lipid asymmetry and integrity, which is critical for cell survival and signaling [1,3].
Enables dietary lipid absorption and lipoprotein assembly, impacting cardiovascular health.
Supports energy homeostasis by mobilizing fatty acids and sterols between tissues [2,8].
Mediates host-pathogen interactions, as pathogens exploit lipid transport for virulence.
Underlies drug resistance mechanisms in bacteria and cancer cells [5,7].
Provides targets for antibiotics that trap lipopolysaccharide in transporters.
Is implicated in neurodegeneration through defects in lipid trafficking.
Offers biomarkers for metabolic and cardiovascular diseases.
Enables synthetic biology approaches to engineer lipid-producing cells.
Facilitates CRISPR screening to identify novel lipid transport regulators [2,8].

What Happens During lipid transport?

Substrate recognition and binding
In simple terms: The transporter first grabs the lipid it needs to move.
Lipid transport begins with the specific recognition and binding of a lipid substrate by a transport protein. For example, ABC transporters such as MsbA bind lipopolysaccharide and other lipids with high specificity, a step that is essential for subsequent translocation [3,6]. Structural studies of human ABCA family transporters have revealed how substrate-binding pockets accommodate diverse lipid species. START-domain proteins bind cholesterol and other lipids via a hydrophobic tunnel, facilitating their transfer between membranes.
Translocation across the membrane
In simple terms: The transporter flips the lipid across the membrane.
Once bound, the lipid is translocated across the lipid bilayer through a conformational cycle of the transporter. ATP-binding cassette transporters utilize ATP hydrolysis to drive alternating access of the substrate-binding site from one side of the membrane to the other [1,3]. Recent structural work on MsbA captured the lipid A transport pathway and identified key residues involved in substrate gating. A new antibiotic, zosurabalpin, traps lipopolysaccharide in its intermembrane transporter, illustrating the druggability of this step.
Release and distribution
In simple terms: The lipid is released on the other side and delivered where needed.
After translocation, the lipid is released into the acceptor compartment or membrane. In eukaryotic cells, START-domain proteins transfer lipids between organelles, contributing to lipid homeostasis and signaling. ABCA transporters release their substrates into the extracellular space or outer leaflet, influencing lipoprotein metabolism and cellular lipid efflux. The directed movement ensures that lipids reach their target destinations, such as mitochondria, peroxisomes, or the plasma membrane.
Coupling to cellular metabolism
In simple terms: Lipid transport is linked to how cells use and store energy.
Lipid transport is tightly coupled to cellular metabolism. Glucose and lipid metabolism are coordinately regulated, and transport steps influence energy storage and utilization. In Mycobacterium tuberculosis, lipid transport across the complex cell envelope is required for virulence and is a target for drug development. The interplay between ion gradients and lipid transport in secondary active transporters highlights the energetic coupling that underlies these processes.

Key Genes Involved in GO:0006869 lipid transport

The following genes and protein families are central to lipid transport, as supported by the cited literature.
GeneMajor RoleResearch Relevance
ABCA1Cholesterol efflux and HDL biogenesisCardiovascular disease, Tangier disease
ABCG1Cholesterol efflux to HDLLipid homeostasis, atherosclerosis
ABCB4Phosphatidylcholine transportLiver disease, cholestasis
ABCB11Bile acid transportCholestasis, drug resistance
MSBALipid A transport in bacteriaAntibiotic target [6,7]
LPTB2FGCLipopolysaccharide transportGram-negative antibiotic development
STARTD1Cholesterol transferSteroidogenesis, neurodegeneration
STARTD3Cholesterol and oxysterol transferLipid signaling
STARTD4Ceramide transferSphingolipid metabolism
STARTD5Cholesterol transferMembrane trafficking
STARTD6Cholesterol transferLipid droplet formation
STARTD7Cholesterol transferSteroidogenesis
STARTD8Cholesterol transferLipid homeostasis
STARTD9Cholesterol transferMitochondrial lipid transport
STARTD10Cholesterol transferLipid signaling
STARTD11Cholesterol transferLipid metabolism
STARTD12Cholesterol transferLipid transport
STARTD13Cholesterol transferLipid transport

How Is lipid transport Regulated?

Lipid transport is regulated at multiple levels, including transcriptional control by lipid-sensing nuclear receptors, post-translational modifications of transporters, and feedback inhibition by substrate availability [2,3]. For example, ABC transporter expression is modulated by cholesterol levels and inflammatory signals. START-domain protein activity can be regulated by phosphorylation and protein-protein interactions. In bacteria, lipid transport is coordinated with cell envelope stress responses.

lipid transport and Human Disease

GeneDisease / BiologyPotential Experimental Model
ABCA1Tangier disease, cardiovascular diseaseKnockout and point-mutation cell models
MSBABacterial infection, antibiotic resistanceBacterial knockout and overexpression [6,7]
STARTD1Neurodegeneration, steroidogenesis defectsKnock-in and knockout models
ABCB11Cholestasis, liver diseaseKnockout hepatocyte models
ABCG1Atherosclerosis, lipid homeostasisOverexpression and knockout macrophages
Cardiometabolic disorders
Defects in lipid transport contribute to dyslipidemia, atherosclerosis, and obesity. ABCA1 mutations cause Tangier disease, characterized by impaired cholesterol efflux. Glucose and lipid metabolism are intertwined, and their dysregulation leads to insulin resistance and type 2 diabetes.
Infectious diseases
Mycobacterium tuberculosis relies on lipid transport for cell envelope integrity and virulence, making these pathways attractive drug targets. In Gram-negative bacteria, lipopolysaccharide transport is essential, and inhibitors such as zosurabalpin show therapeutic promise.
Neurodegeneration
START-domain proteins are implicated in neurodegenerative diseases through their roles in lipid trafficking and signaling. Disrupted cholesterol transport in the brain is associated with Alzheimer's disease and other disorders.
Cancer
Altered lipid transport supports rapid cancer cell proliferation by supplying membranes and signaling lipids. ABC transporters are often overexpressed in drug-resistant cancers, contributing to chemoresistance.

From lipid transport-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of ABCA1 impair cholesterol efflux?ABCA1 knockout cell line
Does a point mutation in MSBA alter lipid A transport?MSBA point-mutation knock-in bacteria
Can STARTD1 overexpression rescue lipid trafficking?STARTD1 overexpression cell model
What is the interactome of ABCG1?Tagged knock-in (e.g., GFP) for proteomics
Which genes regulate lipid transport in macrophages?CRISPR library screening
Does a disease-associated variant affect transporter function?Knock-in of the variant in a model cell line

How to Study the lipid transport Process

MethodWhat It MeasuresTypical Application
CRISPR knockoutLoss-of-function phenotypeIdentify essential lipid transport genes
Point mutationEffect of specific amino acid changesDissect transporter mechanism
Knock-inTagged protein localization and interactionsTrack lipid transporters in live cells
OverexpressionGain-of-function and rescueTest sufficiency of a gene
CRISPR library screeningGenome-wide fitness and lipid phenotypesDiscover novel regulators
LipidomicsLipid species quantificationMeasure transport activity
ProteomicsProtein interactions and abundanceIdentify transport complexes
ImagingSubcellular localization and dynamicsVisualize lipid trafficking
CRISPR knockout and point-mutation models
CRISPR-Cas9 enables the generation of knockout and precise point-mutation cell lines to test the causal role of lipid transport genes. For example, ABCA1 knockout cells show impaired cholesterol efflux, confirming its function. Point mutations in bacterial transporters like MsbA can reveal substrate-binding residues.
Knock-in and tagged knock-in
Knock-in of fluorescent or affinity tags allows visualization and purification of lipid transporters. Tagged START-domain proteins have been used to track lipid transfer between organelles. Knock-in of disease-associated variants helps assess their functional impact.
Overexpression and rescue
Overexpression of lipid transport genes can rescue loss-of-function phenotypes and identify rate-limiting steps. For instance, overexpression of ABCG1 enhances cholesterol efflux. STARTD1 overexpression increases cholesterol transfer in steroidogenic cells.
Library screening and bioinformatics
Genome-wide CRISPR screens coupled with lipid profiling can identify novel regulators of lipid transport. Bioinformatics analysis of transcriptomic and proteomic data reveals pathways and networks associated with lipid transport genes [2,8].

How CRISPR Can Be Used to Study GO:0006869 lipid transport

Knockout

CRISPR knockout of lipid transport genes such as ABCA1 or STARTD1 provides definitive loss-of-function models to study their roles in cholesterol efflux, lipid homeostasis, and disease [4,8]. Knockout cells can be used in lipidomics and imaging assays to quantify transport defects.

Point Mutation

Point mutations introduced by CRISPR base editing or HDR can mimic disease-associated variants or probe catalytic residues. For example, point mutations in MsbA have been used to map the lipid A transport pathway. Such models are valuable for structure-function studies.

Knock-in

Knock-in of tags or reporter genes allows real-time tracking of lipid transporters. Tagged START-domain proteins have revealed their localization and dynamics. Knock-in of disease variants enables personalized drug testing.

Overexpression

CRISPR activation (CRISPRa) or cDNA overexpression can elevate lipid transport gene expression to study gain-of-function effects and rescue phenotypes. Overexpression of ABCG1 increases cholesterol efflux, protecting against atherosclerosis.

How EDITGENE Supports lipid transport Research

Researchers studying lipid transport-related genes often need to determine whether a candidate gene is causally involved in lipid movement, disease pathogenesis, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of lipid transport genes and pathways [2,3,4,8].
Contact EDITGENE today to design your custom CRISPR model for lipid transport research.

Frequently Asked Questions About lipid transport

Lipid transport is the directed movement of lipids into, out of, or within a cell, or between cells, by means of a transporter or pore.
Key genes include ABCA1, ABCG1, ABCB4, ABCB11, MSBA, and START-domain family members such as STARTD1 [3,4,6,8].
It is regulated by lipid-sensing transcription factors, post-translational modifications, and feedback mechanisms [2,3].
Diseases include Tangier disease, atherosclerosis, cholestasis, neurodegeneration, and bacterial infections [4,5,7,8].
CRISPR knockout, point mutation, knock-in, overexpression, lipidomics, proteomics, and imaging are commonly used [2,4,6,8].
Yes, CRISPR enables precise genetic manipulation to test the function of lipid transport genes in cell models [4,8].
ABC transporters use ATP hydrolysis to translocate lipids across membranes, influencing cholesterol efflux and drug resistance [3,4].
START-domain proteins are lipid-binding proteins that transfer lipids between membranes and organelles.
Altered lipid transport supports cancer cell proliferation and contributes to chemoresistance.
EDITGENE provides knockout, point-mutation, knock-in, overexpression, CRISPR library screening, and bioinformatics services [2,3,4,8].

Conclusion

Lipid transport (GO:0006869) is a vital biological process that governs the movement of lipids within and between cells, with profound implications for metabolism, immunity, and disease [1,2,3]. Advances in structural biology and CRISPR-based functional genomics continue to unravel the molecular details of lipid transporters and their regulation [4,6,7,8]. EDITGENE offers a complete toolkit to engineer cell models and screen for lipid transport regulators, empowering researchers to translate these insights into therapeutic breakthroughs [2,3,4,8].

References

  1. 1. Drew D et al.. 2024. Ion and lipid orchestration of secondary active transport.. Nature 626(8001):963-974 PMID: 38418916
  2. 2. Chen L et al.. 2019. Regulation of glucose and lipid metabolism in health and disease.. Sci China Life Sci 62(11):1420-1458 PMID: 31686320
  3. 3. Borst P et al.. 2000. ABC transporters in lipid transport.. Biochim Biophys Acta 1486(1):128-44 PMID: 10856718
  4. 4. Dolai S et al.. 2026. Lipid transport mechanisms in human ABCA family transporters: a structural perspective.. Biochem Soc Trans 54(5):477-488 PMID: 42093645
  5. 5. Bailo R et al.. 2015. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.. Biochem Pharmacol 96(3):159-67 PMID: 25986884
  6. 6. Padayatti PS et al.. 2019. Structural Insights into the Lipid A Transport Pathway in MsbA.. Structure 27(7):1114-1123.e3 PMID: 31130486
  7. 7. Pahil KS et al.. 2024. A new antibiotic traps lipopolysaccharide in its intermembrane transporter.. Nature 625(7995):572-577 PMID: 38172635
  8. 8. Clark BJ. 2012. The mammalian START domain protein family in lipid transport in health and disease.. J Endocrinol 212(3):257-75 PMID: 21965545
Contact Us
*
*
*
*
How did you hear about us: